United Kingdom· GB-APID-15148911000001102
Ondansetron 8mg/4ml solution for injection ampoules
A ondansetron product containing ondansetron, registered in United Kingdom by hameln pharma Ltd. The same ATC class is registered in 19 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ondansetron is registered in 19 of 19 countries.
Countries holding a registration under ATC A04AA01 (ondansetron), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 11 of them publish a price we can compare per daily dose
Ondansetron · ATC A04AA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ondansetron costs, country by country.
Normalised to the WHO defined daily dose (16 mg), the median price runs from $0.23 in United States to $18.43 in Switzerland — a ×79 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ondansetron · price per daily dose (16 mg)
USD · FX 28 Sept 2026
- CH Switzerland$18.43
- IT Italy$14.68
- FR France$5.36
- US United States$0.23 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ondansetron
- Manufacturer
- hameln pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- A04AA01
- ATC class
- Ondansetron
- Defined daily dose
- 16 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4260016650606
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
841 interactions on record for ondansetron.
Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ondansetron · interactions on record
841 records
- 139 severe
- 240 moderate
- 6 minor
- 402 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ondansetron in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesondansetronBryant Ranch Prepack
- CzechiaNOVETRONPHARMAGEN CZ s.r.o., Praha
- FinlandEmeondanAlfred E.Tiefenbacher GmbH & Co. KG
- CanadaACCEL-ONDANSETRONACCEL PHARMA INC
- BelgiumAvessaron 4 mgSandoz
- GermanyCellondanStadapharm Gmbh
- SpainONDANSETRON ACCORD 2 mg/ml SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- SwedenOndansetron 2care4 4 mg Munsönderfallande tablett2care4 ApS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ondansan, Ondansan I.V.
- Belgium · Ondansetron Ab, Ondansetron Accord Healthcare
- Bulgaria · Zofran, Зондарон
- Cyprus · Ondansetron Accord, Ondansetron Noridem
- Czechia · Novetron, Ondansetron Accord
- Germany · Cellondan, Ondansetron 1 A Pharma
- Denmark · Ondansetron "kalceks", Ondansetron "stada"
- Estonia · Ondansetron Accord, Ondansetron Basi
- Spain · Ondansetrón Accord, Ondansetron Aristo
- Finland · Ondansetron Accord, Ondansetron Accordpharma
- France · Ondansetron Accord, Ondansetron Arrow
- Greece · Cruzafen, Odasen
- Croatia · Ondansetron Kalceks, Ondanzetron Kabi
- Hungary · Emetron, Ondansetron Kabi
- Ireland · Emizof, Ondansetron Accord Healthcare Ireland
- Iceland · Cinveron, Ondansetron Bluefish
- Italy · Emistop, Ondansetron Accord
- Lithuania · Ondansetron Accord, Ondansetron Basi
- Luxembourg · Avessaron, Ondansetron B. Braun
- Latvia · Emetron, Ondansetron Accord
- Malta · Emytron, Ondansetron Accord Healthcare Ireland
- Netherlands · Ondansetron Accord, Ondansetron Aspire
- Norway · Ondansetron Accord, Ondansetron Accordpharma
- Poland · Atossa, Ondansetron Accord
- Portugal · Danevon, Emytron
- Romania · Ondansetron Aurobindo, Ondansetron Kabi
- Sweden · Ondansetron Accord, Ondansetron Accordpharma
- Slovenia · Ondansetron Accord, Ondansetron Baxter
- Slovakia · Ondansetron Accord, Ondansetron B. Braun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9f45fd1-d402-4c5c-b87f-de9111c816f9 GET /v1/drugs/e9f45fd1-d402-4c5c-b87f-de9111c816f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "15148911000001102",
"desc": "Ondansetron 8mg/4ml solution for injection ampoules (hameln pharma Ltd)",
"form": "Solution for injection",
"vpid": "36022511000001103",
"source": "dmd",
"vtm_id": "776993002",
"strength": "2 mg",
"substance": "Ondansetron",
"ingredient": "Ondansetron hydrochloride dihydrate",
"supplier_code": "2083101000001106"
}See everything about ondansetron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.